XT
XTX Topco’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,907
| Closed | -$371K | – | 2494 |
|
|
2025
Q1 | $371K | Buy |
10,907
+1,988
| +22% | +$67.7K | 0.02% | 1247 |
|
|
2024
Q4 | $351K | Sell |
8,919
-21,103
| -70% | -$831K | 0.03% | 1074 |
|
|
2024
Q3 | $1.41M | Buy |
30,022
+22,402
| +294% | +$1.05M | 0.1% | 274 |
|
|
2024
Q2 | $412K | Sell |
7,620
-3,071
| -29% | -$166K | 0.04% | 755 |
|
|
2024
Q1 | $729K | Buy |
10,691
+6,827
| +177% | +$465K | 0.1% | 279 |
|
|
2023
Q4 | $242K | Sell |
3,864
-18,093
| -82% | -$1.13M | 0.05% | 804 |
|
|
2023
Q3 | $997K | Buy |
21,957
+6,583
| +43% | +$299K | 0.17% | 97 |
|
|
2023
Q2 | $863K | Buy |
+15,374
| New | +$863K | 0.15% | 130 |
|
|
2022
Q3 | – | Sell |
-5,233
| Closed | -$318K | – | 1143 |
|
|
2022
Q2 | $318K | Buy |
+5,233
| New | +$318K | 0.13% | 251 |
|
|
2021
Q4 | – | Sell |
-7,248
| Closed | -$811K | – | 740 |
|
|
2021
Q3 | $811K | Buy |
7,248
+2,670
| +58% | +$299K | 0.27% | 79 |
|
|
2021
Q2 | $741K | Buy |
+4,578
| New | +$741K | 0.25% | 77 |
|